chr18-31069003-GC-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP5
The NM_024422.6(DSC2):c.2398del(p.Ala800LeufsTer56) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000041 in 1,461,838 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000041 ( 0 hom. )
Consequence
DSC2
NM_024422.6 frameshift
NM_024422.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.00800
Genes affected
DSC2 (HGNC:3036): (desmocollin 2) This gene encodes a member of the desmocollin protein subfamily. Desmocollins, along with desmogleins, are cadherin-like transmembrane glycoproteins that are major components of the desmosome. Desmosomes are cell-cell junctions that help resist shearing forces and are found in high concentrations in cells subject to mechanical stress. This gene is found in a cluster with other desmocollin family members on chromosome 18. Mutations in this gene are associated with arrhythmogenic right ventricular dysplasia-11, and reduced protein expression has been described in several types of cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 18-31069003-GC-G is Pathogenic according to our data. Variant chr18-31069003-GC-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 46180.We mark this variant Likely_pathogenic, oryginal submissions are: {Likely_pathogenic=3, Uncertain_significance=2}. Variant chr18-31069003-GC-G is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DSC2 | NM_024422.6 | c.2398del | p.Ala800LeufsTer56 | frameshift_variant | 15/16 | ENST00000280904.11 | NP_077740.1 | |
DSC2 | NM_004949.5 | c.2398del | p.Ala800LeufsTer45 | frameshift_variant | 15/17 | NP_004940.1 | ||
DSC2 | NM_001406506.1 | c.1969del | p.Ala657LeufsTer56 | frameshift_variant | 15/16 | NP_001393435.1 | ||
DSC2 | NM_001406507.1 | c.1969del | p.Ala657LeufsTer45 | frameshift_variant | 15/17 | NP_001393436.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DSC2 | ENST00000280904.11 | c.2398del | p.Ala800LeufsTer56 | frameshift_variant | 15/16 | 1 | NM_024422.6 | ENSP00000280904 | P1 | |
DSC2 | ENST00000251081.8 | c.2398del | p.Ala800LeufsTer45 | frameshift_variant | 15/17 | 1 | ENSP00000251081 | |||
DSC2 | ENST00000648081.1 | c.1969del | p.Ala657LeufsTer56 | frameshift_variant | 16/17 | ENSP00000497441 | ||||
DSC2 | ENST00000682357.1 | c.1969del | p.Ala657LeufsTer56 | frameshift_variant | 15/16 | ENSP00000507826 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461838Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727214
GnomAD4 exome
AF:
AC:
6
AN:
1461838
Hom.:
Cov.:
31
AF XY:
AC XY:
4
AN XY:
727214
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Pathogenic:3
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Apr 01, 2023 | DSC2: PVS1:Strong, PM2 - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 31, 2023 | Frameshift variant predicted to result in abnormal protein length as the last 102 amino acids are replaced with 55 different amino acids, and other similar variants have been reported in HGMD; Reported in conjunction with a pathogenic PKP2 variant in an individual with arrhythmogenic cardiomyopathy (PMID: 28069705); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 32880476, 35819174, 31386562, 28069705) - |
Likely pathogenic, criteria provided, single submitter | clinical testing | AiLife Diagnostics, AiLife Diagnostics | Aug 31, 2021 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Apr 17, 2012 | Variant classified as Uncertain Significance - Favor Pathogenic. The 2398delG va riant (DSC2) has not been reported in the literature but has been identified in 1 individual with ARVD/C (this individual) tested by our laboratory. This frames hift variant is predicted to alter the protein?s amino acid sequence beginning a t position 800 and lead to a premature termination codon 56 amino acids downstre am. Premature termination often leads to degradation of the mRNA and therefore reduced or absent protein; however, this typically does not happen when the prem ature stop codon is located in the last exon as is the case in this individual. In summary, the presence of a variant in the DSC2 gene is consistent with this i ndividual?s clinical diagnosis. However, there is not yet enough data on whethe r this type of variant would cause ARVC. It is more likely that this variant ca uses disease but additional information is needed to establish this with confide nce. - |
Arrhythmogenic right ventricular dysplasia 11 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 15, 2022 | This sequence change creates a premature translational stop signal (p.Ala800Leufs*56) in the DSC2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 102 amino acid(s) of the DSC2 protein. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 46180). This premature translational stop signal has been observed in individual(s) with clinical features of DSC2-related conditions (PMID: 28069705, 32880476). This variant is not present in population databases (gnomAD no frequency). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at